Pre-radiotherapy systemic immune inflammation index associated with overall survival in patients with advanced EGFR mutant non-small cell lung cancer receiving thoracic radiotherapy

PURPOSE: This study aimed to investigate the prognostic potential of the pre-radiotherapy systemic immune-inflammation index (SII) for the survival of advanced lung adenocarcinoma patients with epidermal growth factor receptor (EGFR) mutations, which might provide a basis for optimizing the comprehe...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Dujuan, Qin, Hongyue, Deng, Guangchuan, Wang, Qi, Wang, Haiyong, Liu, Xijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813231/
https://www.ncbi.nlm.nih.gov/pubmed/36070068
http://dx.doi.org/10.1007/s12094-022-02936-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813231/
https://www.ncbi.nlm.nih.gov/pubmed/36070068
http://dx.doi.org/10.1007/s12094-022-02936-2

Ejemplares similares